Trotter JF - Search Results

1

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.

Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM. Asrani SK, et al. Among authors: trotter jf. Am J Transplant. 2014 Feb;14(2):356-66. doi: 10.1111/ajt.12543. Epub 2014 Jan 23. Am J Transplant. 2014. PMID: 24456026 Free article. Clinical Trial.

2

Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation.

Trotter JF, Brazer SR. Trotter JF, et al. Liver Transpl Surg. 1999 Jul;5(4):332-3. doi: 10.1002/lt.500050405. Liver Transpl Surg. 1999. PMID: 10388506 Free article.

3

Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).

Trotter JF, Wachs M, Bak T, Trouillot T, Stolpman N, Everson GT, Kam I. Trotter JF, et al. Liver Transpl. 2001 Apr;7(4):343-51. doi: 10.1053/jlts.2001.23012. Liver Transpl. 2001. PMID: 11303295 Free article.

4

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.

Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G. Trotter JF, et al. Liver Transpl. 2001 May;7(5):401-8. doi: 10.1053/jlts.2001.23916. Liver Transpl. 2001. PMID: 11349259 Free article.

5

Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.

Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT. Trotter JF, et al. Liver Transpl. 2002 Mar;8(3):212-8. doi: 10.1053/jlts.2002.31346. Liver Transpl. 2002. PMID: 11910565 Free article.

6

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications.

Dunkelberg JC, Trotter JF, Wachs M, Bak T, Kugelmas M, Steinberg T, Everson GT, Kam I. Dunkelberg JC, et al. Among authors: trotter jf. Liver Transpl. 2003 May;9(5):463-8. doi: 10.1053/jlts.2003.50079. Liver Transpl. 2003. PMID: 12740787 Free article. Clinical Trial.

7

Sirolimus in liver transplantation.

Trotter JF. Trotter JF. Transplant Proc. 2003 May;35(3 Suppl):193S-200S. doi: 10.1016/s0041-1345(03)00234-3. Transplant Proc. 2003. PMID: 12742496 Review.

8

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Hayashi PH, et al. Among authors: trotter jf. Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122. Liver Transpl. 2003. PMID: 12827562 Free article.

9

Living donor liver transplantation in patients with hepatitis C.

Zimmerman MA, Trotter JF. Zimmerman MA, et al. Among authors: trotter jf. Liver Transpl. 2003 Nov;9(11):S52-7. doi: 10.1053/jlts.2003.50256. Liver Transpl. 2003. PMID: 14586896 Free article. Review.

10

Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper.

Trotter JF, Wallack A, Steinberg T. Trotter JF, et al. Transpl Infect Dis. 2003 Dec;5(4):174-80. doi: 10.1111/j.1399-3062.2003.00032.x. Transpl Infect Dis. 2003. PMID: 14987201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page